MILLA PHARMACEUTICALS
Live / Registered — Registered (as of 12 Jan 2021)
What this means for you
Registered since 12 Jan 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87235737
- Registration number
- 6245672
- Mark type
- Stylized text
- Filed
- 14 Nov 2016
- Published for opposition
- 30 May 2017
- Registered
- 12 Jan 2021
- Attorney of record
- Jeffrey S. Ward
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for prevention and correction of metabolic acidosis, prevention and treatment of hyponatremia, use as an additive for preparing intravenous fluid formulas, prevention and control of seizures in preeclampsia and eclampsia, and for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes
Owner
- Milla Pharmaceuticals, Inc., Minnetonka, MN, US
- Milla Pharmaceuticals, Inc., Minnetonka, MN, US
- Milla Pharmaceuticals, Inc., Minnetonka, MN, US
Prosecution history
- 17 Feb 2026 — TEAS SECTION 8 & 15 RECEIVED
- 12 Jan 2026 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 14 Jan 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 14 Jan 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 14 Jan 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 12 Jan 2021 — REGISTERED-PRINCIPAL REGISTER
- 10 Dec 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Dec 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Dec 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Dec 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Nov 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 May 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 May 2020 — NON-FINAL ACTION E-MAILED
- 14 May 2020 — SU - NON-FINAL ACTION - WRITTEN
- 14 May 2020 — STATEMENT OF USE PROCESSING COMPLETE